Stay updated on Olaparib in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib in BRCA Ovarian Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5, marking a new version of the page for tracking updates. This change is a non-substantive metadata update and does not modify the study details or results.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check25 days agoChange DetectedThe page revision tag has been updated to Revision: v3.5.4, replacing the previous v3.5.3, indicating a small update to the page's revision history.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page’s footer revision/version indicator was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check68 days agoChange DetectedPadova, Italy was added to the locations list and Padua, Italy was removed.SummaryDifference0.0%

- Check82 days agoChange DetectedNapoli, Italy was replaced with Naples, Italy and the Naples site was added to the study locations. The page revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Olaparib in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib in BRCA Ovarian Cancer Clinical Trial page.